Patients & CaregiversHealthcare ProfessionalsWorldwide
HomeAbout MerckProductsNewsroomInvestor RelationsCareersResearchLicensingThe Merck Manuals
THE MERCK MANUAL MEDICAL LIBRARY: The Merck Manual of Medical Information--Home Edition
Tips for better results
ABCDEFGHI
JKLMNOPQR
STUVWXYZ

Section

Subject

Topics

Heavy Chain Diseases

Pronunciations

Heavy chain diseases are plasma cell cancers in which a clone of plasma cells produces a large quantity of pieces of abnormal antibodies called heavy chains.

Heavy chain diseases are categorized according to the type of heavy chain produced: alpha, gamma, or mu.

Alpha heavy chain disease affects mainly younger adults of Middle Eastern or Mediterranean ancestry. Infiltration of the intestinal tract wall by cancerous plasma cells often prevents proper absorption of nutrients from food (malabsorption), resulting in severe diarrhea and weight loss. Alpha heavy chain disease progresses rapidly, and half of the affected people die within 1 year. Treatment with cyclophosphamideSome Trade Names
CYTOXAN
, prednisoneSome Trade Names
DELTASONE
METICORTEN
(a corticosteroid), and antibiotics may slow the progression of the disease.

Gamma heavy chain disease affects mainly older adults. Some people with gamma heavy chain disease have no symptoms. Infiltration of the bone marrow by cancerous plasma cells causes other people to have symptoms of recurring infections, such as repeated episodes of fever and chills associated with a decreased number of white blood cells, and fatigue and weakness associated with severe anemia. Cancerous plasma cells may also enlarge the liver and spleen. People with symptoms may respond to therapy with cyclophosphamideSome Trade Names
CYTOXAN
and prednisoneSome Trade Names
DELTASONE
METICORTEN
.

Mu heavy chain disease, the rarest of the three heavy chain diseases, may cause enlargement of the liver and spleen as well as enlargement of the lymph nodes in the abdomen. Length of survival and response to chemotherapy drugs vary widely.

Last full review/revision February 2003

Back to Top

Previous: Introduction

Next: Macroglobulinemia

Audio
Figures
Photographs
Pronunciations
Tables
Videos
Contact UsSite MapPrivacy PolicyTerms of UseCopyright 1995-2007 Merck & Co., Inc.